CD4 cell counts and plasma viral RNA are measured every 4 weeks for the duration of the study. Physical examination and laboratory tests of blood and urine are performed every 4 weeks for the duration of the study. Phase Phase II A phase two trial follows phase one. It consists of a larger, randomized sample of patients. The purpose of a phase two trial is to see if the drug is effective at doing what the manufacturer claims it should do.
Researchers also watch closely for unexpected adverse reactions.
These increases in viral RNA should not be attributable to intercurrent infection, vaccination, or temporary interruption of therapy. These increases in viral RNA should not be attributable to intercurrent infection, vaccination, or temporary interruption of therapy. Naive to at least one of the selected NRTIs. Always watch for outdated information. This information is designed to support, not replace, the relationship that exists between you and your doctor.